A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose
Lung Cancer, Left Sided Breast Cancer
About this trial
This is an interventional supportive care trial for Lung Cancer focused on measuring stereotactic body radiation therapy, continuous positive airway pressure, CPAP, radiation, cancer, lung, Deep inspiratory breath hold (DIBH)
Eligibility Criteria
Inclusion Criteria:
Patients with left-sided breast cancers
- Patients must be undergoing left breast/chest wall radiation with or without regional nodal irradiation
Patients undergoing lung SBRT
- Primary lung cancers
- Metastatic lung tumors
Exclusion Criteria:
- Patients with right side breast cancer
- Patients who are unable to tolerate the CPAP device
Sites / Locations
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
left-sided breast cancer
Lung SBRT
Participants will come in for their regularly scheduled radiation planning and treatment. Participants will undergo three scans (with and without DIBH (i.e., free-breathing), with CPAP). Participants will also use the CPAP device before the CT scan, for which they will be educated and trained.
Participants will come in for their regularly scheduled radiation planning and treatment. Participants will undergo three scans (with and without DIBH (i.e., free-breathing), with CPAP). Participants will also use the CPAP device before the CT scan, for which they will be educated and trained.